Allied Health & Imaging · Independent exam preparation
MLT(ASCP) Preparation Guide: Laboratory Decisions and Calculations Study Guide
Practise compatibility decisions, specimen troubleshooting, laboratory calculations, and result interpretation across all seven MLT(ASCP) examination domains.
By CertMedbry · Updated 31 October 2026
Learn to reconcile blood bank results, distinguish disease patterns from specimen artifacts, calculate reportable results, and choose informative follow-up tests. These 60 selected concepts connect laboratory mechanisms with practical decisions across all seven domains. The official ASCP BOC examination content outline defines the full scope; use it alongside this guide to identify additional topics requiring study.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and pathway does this guide address?
The target is MLT(ASCP), awarded by ASCP BOC. The issuer's examination guideline also covers MLT(ASCPi), but international eligibility pathways differ. Sharing a content guideline does not make the credentials or eligibility requirements interchangeable. Other organizations' MLT credentials require their own preparation outlines.
ASCP BOC: Medical Laboratory Technician · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
How many questions are on the examination, and how long is it?
The guideline specifies 100 questions in 2 hours 30 minutes, or 150 minutes. It does not identify a separate scored-versus-pretest breakdown, so no such split is asserted here.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
What delivery model and question styles are verified?
The examination uses computer adaptive testing. All questions are multiple-choice with one best answer. Questions may test theoretical application, calculations, correlation of results with disease states, laboratory procedures, and quality assurance. The 20 questions here are independent learning drills; they do not reproduce adaptive delivery or predict a passing result.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
Which blueprint version and jurisdiction apply?
The shared MLT(ASCP)/MLT(ASCPi) guideline is revised June 9, 2026. It does not separately state an implementation date. Regulatory questions use U.S. sources, and donor eligibility questions reflect regulations current as of June 2026. Canadian Blood Services references in this guide support transfusion mechanisms and serologic principles; Canadian specimen-validity and component-expiration rules are not presented as U.S. requirements.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline · Canadian Blood Services: Pre-transfusion testing
What are the official domain weights?
Blood Banking: 15–20%; Urinalysis and Other Body Fluids: 5–10%; Chemistry: 20–25%; Hematology: 20–25%; Immunology: 5–10%; Microbiology: 15–20%; Laboratory Operations: 5–10%. These are published ranges rather than one fixed allocation.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
How is this guide distributed across the blueprint?
The 60 concepts comprise 10 Blood Banking, 5 Urinalysis and Other Body Fluids, 13 Chemistry, 12 Hematology, 5 Immunology, 10 Microbiology, and 5 Laboratory Operations concepts. Both the 20 questions and 20 flashcards allocate 3, 1, 5, 5, 1, 3, and 2 items respectively. These small sets approximate the official ranges and remain selective.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
Which calculations and reference ranges should candidates study?
The guideline lists transferrin saturation, UIBC/TIBC, indirect bilirubin, lipid calculations, A/G ratio, timed urine and creatinine clearance, Beer's law, corrected WBC counts, hemocytometer counts, RBC indices, and absolute cell counts. Its composite examination reference ranges must be learned because those listed ranges will not be supplied during the examination. Other ranges will be supplied as needed. Results appear in conventional and SI units. The examination ranges are not clinical reference standards.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
This guide targets the American Society for Clinical Pathology Board of Certification Medical Laboratory Technician credential, MLT(ASCP). It develops technician-level laboratory reasoning through independently authored explanations, questions, and flashcards.
Outline used: Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline, revised June 9, 2026. This guide targets MLT(ASCP).
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Blood Banking15–20%
1.How do forward and reverse ABO grouping confirm each other?
Forward grouping detects A and B antigens on patient red cells; reverse grouping detects expected plasma antibodies using reagent A and B cells. In a typical adult, group A cells react with anti-A while plasma reacts with B cells. Agreement supports the interpretation because the tests examine complementary sides of the ABO system. A discrepancy requires investigation before assigning a valid routine ABO result or selecting group-specific components.
Apply it
An adult's cells react with anti-A but not anti-B. Plasma reacts with B cells but not A cells. Interpret the concordant findings as group A, then complete RhD typing, antibody screening, and required compatibility testing.
Common pitfall: Using forward typing alone overlooks weak or unexpected reactions in reverse grouping. Expected adult antibody patterns also cannot be applied unchanged to young infants.
2.Why must an ABO discrepancy be resolved before routine group-specific release?
An ABO discrepancy means the detected red cell antigens and plasma antibody pattern do not support one coherent interpretation. Possible explanations include sample identification problems, weak antigen expression, missing expected antibodies, or unexpected reactivity. Repeating the same tube without checking identity and the separate forward and reverse reactions may reproduce the error. The important decision is to investigate the discordance rather than force an ABO label from the stronger-looking result.
Apply it
A patient's forward grouping suggests group A, but plasma reacts with both reagent A and B cells. Review identification, previous results, specimen quality, and reaction conditions before accepting a group and proceeding with routine group-specific selection.
Common pitfall: A familiar historical group does not make a conflicting current specimen valid. Historical information guides investigation but cannot substitute for resolving the discrepancy.
3.How does RhD exposure create risk in a later pregnancy?
RhD-negative individuals lack the D antigen and can form anti-D after exposure to D-positive red cells through transfusion or pregnancy. Maternal IgG anti-D can cross the placenta and bind fetal D-positive cells, producing hemolytic disease of the fetus and newborn. The discriminating issue is antigen exposure followed by an immune response, rather than an automatically present antibody. Preventing avoidable D exposure is especially important for patients with future pregnancy potential.
Apply it
A D-negative patient with pregnancy potential requires a routine red cell transfusion. Selecting D-negative red cells avoids an unnecessary D-antigen exposure that could lead to sensitization and complicate a future D-positive pregnancy.
Common pitfall: D-negative status alone does not mean anti-D is already present. Conversely, a negative current antibody screen does not justify unnecessary exposure to D-positive cells.
4.What separates an antibody screen from antibody identification?
An antibody screen tests patient plasma against selected group O reagent red cells to detect potentially significant non-ABO antibodies. A positive screen establishes reactivity but usually does not establish specificity. Identification uses a larger panel with known antigen profiles to compare reactive and nonreactive cells. Temperature, method, patient antigen status, and possible autologous reactivity help distinguish a clinically significant alloantibody from other causes of positive reactions.
Apply it
A preoperative screen is positive with two screening cells. Begin an identification panel instead of naming an antibody from those two reactions. Use the completed investigation to determine which donor antigens must be avoided.
Common pitfall: A positive screen does not automatically mean every donor unit is incompatible. Compatibility depends on the antibody's specificity and the donor cells' corresponding antigen expression.
5.How does an antibody panel guide antigen-negative unit selection?
Panel interpretation compares patient plasma reactions with the antigen profiles of reagent cells. A proposed specificity must explain the pattern and survive appropriate exclusion of alternatives; more than one antibody may be present. Patient phenotyping or genotyping can provide additional support. Once a clinically significant alloantibody is established, donor units lacking its corresponding antigen are selected and tested for compatibility. Antigen matching and crossmatching answer related but different questions.
Apply it
An investigation identifies anti-K in a patient needing red cells. Select units documented to lack K, then perform the required serologic crossmatch. ABO compatibility alone would not address this additional antigen-antibody risk.
Common pitfall: One reactive antigen-positive cell is insufficient proof of specificity. Coincidental antigen combinations can make an incomplete panel appear more conclusive than it is.
6.Why does a historical alloantibody still affect crossmatching?
An alloantibody may fall below the detection threshold while immunologic memory persists. A negative current screen therefore does not erase a documented clinically significant antibody. Subsequent antigen exposure can provoke a secondary response. Electronic crossmatching requires both a negative current screen and no history of a clinically significant antibody, along with a validated system. Historical specificity remains relevant when selecting antigen-negative red cells and arranging serologic compatibility testing.
Apply it
A patient's current screen is negative, but records document anti-Jka after an earlier transfusion. Retain the antibody history, select Jka-negative red cells, and use the appropriate serologic compatibility process rather than treating the screen as an unrestricted clearance.
Common pitfall: Choosing electronic crossmatching solely because today's screen is negative ignores antibody evanescence. A previously documented significant antibody remains meaningful even when currently undetectable.
7.What distinguishes direct from indirect antiglobulin testing?
The direct antiglobulin test detects immunoglobulin or complement already attached to the patient's red cells. Indirect antiglobulin methods detect plasma antibodies after controlled incubation with reagent or donor cells. Their specimen targets differ: cell coating versus circulating antibody capable of binding test cells. A positive direct test supports immune coating but does not independently establish active hemolysis. Interpret it with hemoglobin trends, bilirubin, LDH, haptoglobin, and clinical circumstances.
Apply it
A patient has anemia, increased indirect bilirubin, and a positive direct antiglobulin test. The combination supports investigation of immune hemolysis. An antibody screen separately evaluates circulating antibodies relevant to donor cell selection.
Common pitfall: Calling every positive direct antiglobulin result hemolytic anemia confuses a binding finding with cell destruction. Hemolysis requires independent biochemical and hematologic evidence.
ARUP Laboratories: Hemolytic Anemias · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
8.How does component storage change extracellular potassium?
During red cell storage, potassium moves from cells into the surrounding fluid. Irradiation accelerates membrane-related potassium leakage, so the supernatant can contain more potassium even though the product remains a red cell component. This matters particularly when a vulnerable recipient receives a large potassium load rapidly. Washing can reduce extracellular potassium by removing supernatant, but processing also affects product availability, cell recovery, and the conditions governing subsequent storage.
Apply it
A neonatal transfusion plan involves previously irradiated red cells. Recognize supernatant potassium as a relevant product characteristic and communicate the need for component preparation appropriate to the prescribed neonatal transfusion protocol before issue.
Common pitfall: Irradiation does not preserve red cell membranes or remove potassium. Storage and postprocessing expiration decisions must use the applicable product and jurisdictional requirements.
Canadian Blood Services: Irradiated, washed and CMV seronegative blood components
9.Why does irradiation prevent transfusion-associated graft-versus-host disease?
Transfusion-associated graft-versus-host disease occurs when viable donor T lymphocytes survive, proliferate, and attack recipient tissues. Irradiation damages lymphocyte DNA sufficiently to prevent proliferation. The target is donor immune cell replication, not plasma proteins or recipient antibodies. Leukocyte reduction alone does not reliably prevent this complication. Components donated by relatives and HLA-selected cellular components are important settings in which donor-recipient immune similarity creates risk.
Apply it
A patient will receive a cellular component donated by a relative. Identify prevention of donor T-cell proliferation as the reason for the prescribed irradiation requirement, and verify that the component modification is documented before release.
Common pitfall: Washing and leukocyte reduction are tempting substitutes because both alter cellular products. Neither provides the same reliable prevention of donor lymphocyte proliferation as irradiation.
Canadian Blood Services: Irradiated, washed and CMV seronegative blood components
10.When does washing address a transfusion component problem?
Washing removes much of the residual plasma and soluble supernatant material from cellular components. This can reduce exposure to plasma proteins in selected patients with severe or recurrent allergic transfusion reactions and can reduce extracellular potassium. The mechanism differs from irradiation, which prevents lymphocyte replication. Washing also loses some cells and changes processing and storage considerations. IgA deficiency alone does not establish that every subsequent cellular component must be washed.
Apply it
A transfusion service evaluates a patient with recurrent severe allergic reactions to red cells. Washing is considered because removing residual plasma proteins addresses the suspected exposure; irradiation would address a different transfusion complication mechanism.
Common pitfall: Automatically ordering washed components for an isolated low IgA result overlooks reaction history. Component selection should match the demonstrated problem and the modification's mechanism.
Canadian Blood Services: Irradiated, washed and CMV seronegative blood components
Urinalysis and Other Body Fluids5–10%
11.Why can urine test positive for blood without visible red cells?
The cited Siemens blood pad detects peroxidase-like heme activity rather than counting intact erythrocytes. Hemoglobin and myoglobin can produce positive reactions, while microscopy may show few or no red cells. Cell lysis and oxidizing contamination are additional explanations for discordance. Correlation with specimen condition, microscopic findings, and other laboratory results distinguishes intact-cell hematuria from pigment detection. The strip alone cannot identify which heme-containing pigment is responsible.
Apply it
A fresh urine specimen has a strongly positive blood pad and almost no erythrocytes microscopically. Investigate pigmenturia and possible interference instead of reporting that microscopy confirms heavy hematuria; use other findings to distinguish hemoglobin from myoglobin.
Common pitfall: Equating a positive blood pad with an increased microscopic RBC count mistakes chemical detection for cell enumeration. The two methods measure related but different features.
Siemens Healthcare Diagnostics: Urinalysis Reagent Strips Package Insert · ARUP Laboratories: Hemolytic Anemias
12.Why does negative urine nitrite fail to exclude infection?
Nitrite detection depends on dietary nitrate, organisms capable of nitrate reduction, and sufficient time in the bladder for nitrite accumulation. Frequent voiding, limited nitrate availability, or nonreducing organisms can yield a negative result despite bacteriuria. Leukocyte esterase detects granulocyte enzyme activity and supplies different information about inflammation. Neither a negative nitrite pad nor isolated pyuria independently settles whether a clinically significant urinary infection is present.
Apply it
A patient with urinary symptoms voids frequently. Urine shows leukocyte esterase and microscopic leukocytes but negative nitrite. Recognize short bladder retention as one explanation and interpret the complete urinalysis alongside the indicated microbiologic investigation.
Common pitfall: Treating nitrite as a universal bacterial marker overlooks organism metabolism and collection timing. Positive leukocyte esterase also does not prove that inflammation is infectious.
Siemens Healthcare Diagnostics: Urinalysis Reagent Strips Package Insert
13.Which ketone does the cited urine reagent strip detect?
The cited Siemens ketone pad detects acetoacetic acid and does not detect beta-hydroxybutyrate or acetone. Consequently, its result is not a measurement of all ketone bodies. A negative or modest urine reaction can coexist with substantial beta-hydroxybutyrate accumulation. The useful decision is to identify the analyte each method measures before comparing results, especially when evaluating a patient whose acid-base findings suggest a more substantial metabolic disturbance.
Apply it
A patient has hyperglycemia and metabolic acidosis, but the cited urine strip shows only trace ketone. A blood beta-hydroxybutyrate measurement answers a different analytical question and can clarify the apparent mismatch with the urine result.
Common pitfall: Assuming every nitroprusside-based product detects the same ketones overgeneralizes a method family. Apply the specific manufacturer's stated analyte reactivity and limitations.
Siemens Healthcare Diagnostics: Urinalysis Reagent Strips Package Insert
14.How do casts localize urinary sediment findings?
Casts form within renal tubules from a protein matrix that may incorporate cells or other material. Their cylindrical matrix distinguishes them from isolated cells and many crystals. Red cell casts therefore indicate a renal source of bleeding, while white cell casts support inflammation within the kidney rather than simply leukocytes somewhere in the urinary tract. Interpretation requires recognizable cast structure, incorporated contents, and correlation with the remainder of the sediment.
Apply it
Microscopy shows erythrocytes embedded within cylindrical protein structures. Recognize red cell casts and distinguish this finding from free erythrocytes introduced by lower urinary tract bleeding or contamination, which would not by themselves establish intrarenal cast formation.
Common pitfall: A cluster of cells or an elongated crystal is not automatically a cast. Confirm a matrix and characteristic outline before assigning renal localization.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
15.How is a manual body-fluid cell concentration calculated?
A hemocytometer measures cells in a defined chamber volume. Cell concentration equals cells counted multiplied by the dilution factor, divided by the volume examined. Area and chamber depth determine that volume; one cubic millimeter equals one microliter. Body-fluid calculations require careful attention to low counts, uniform distribution, and consistent boundary rules. A numerical result should be checked against chamber agreement and specimen quality before it is interpreted as a biologic finding.
Apply it
A diluted fluid yields 40 cells in a counted volume of 0.4 microliter. With a dilution factor of 2, calculate 40 × 2 ÷ 0.4 = 200 cells per microliter before considering the fluid-specific interpretation.
Common pitfall: Multiplying by a remembered chamber constant without verifying counted area can produce a tenfold error. Dilution and chamber volume must both appear in the calculation.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
Chemistry20–25%
16.When does an A1C result meet a diabetes diagnostic threshold?
A1C reflects hemoglobin glycation over the preceding months rather than glucose at one moment. An A1C of 6.5% or higher meets the diagnostic threshold for diabetes when an appropriate laboratory method is used. In a person without clear symptoms, an abnormal result requires confirmation with repeat A1C or another diagnostic glucose test. The threshold is a diagnostic decision limit; it is not interchangeable with a treatment target for someone already diagnosed.
Apply it
An asymptomatic adult has a laboratory A1C of 6.7% and no known interference. Recognize a result in the diabetes range, while identifying confirmation as necessary before making a diagnosis from this isolated finding.
Common pitfall: Calling one asymptomatic abnormal result a fully confirmed diagnosis skips confirmation. Conversely, treating the diagnostic threshold as everyone's therapeutic goal confuses two different uses.
17.Why can altered red cell survival distort A1C?
Hemoglobin glycation accumulates during red cell circulation. Shortened survival, as in hemolysis or recent blood loss, reduces time available for glycation and can lower A1C relative to actual glucose exposure. Recent transfusion can also complicate interpretation by introducing donor cells. Hemoglobin variants may introduce method-dependent effects. When A1C and glucose disagree, distinguish altered cell biology from analytical interference rather than assuming the patient's glucose measurements must be wrong.
Apply it
A patient with active hemolysis has repeatedly high plasma glucose but a surprisingly low A1C. Identify shortened erythrocyte survival as a plausible explanation and use suitable glucose-based assessment rather than accepting A1C as an unbiased average.
Common pitfall: Repeating A1C with the same method may reproduce a biologically misleading result. Changing analytical methods cannot restore the patient's missing normal red cell lifespan.
18.How do TSH and free T4 reveal primary thyroid dysfunction?
Pituitary TSH stimulates thyroid hormone production, while circulating thyroid hormones suppress further TSH release through negative feedback. Primary thyroid failure therefore commonly produces low free T4 with increased TSH. Primary hyperthyroidism commonly produces increased thyroid hormone with suppressed TSH. Total T4 includes bound hormone: increased binding proteins during pregnancy or estrogen use can increase total T4 while free T4 and TSH remain normal. Interpret the paired feedback pattern and the measured hormone fraction.
Apply it
Low free T4 with clearly increased TSH supports primary thyroid failure. In contrast, increased total T4 with normal free T4 and TSH in a patient taking estrogen supports a binding-protein effect rather than excess available thyroid hormone.
Common pitfall: Assuming low TSH always means excess thyroid hormone ignores central disease and other causes of suppression. Total T4 is also not interchangeable with free T4.
19.How do enzyme patterns distinguish hepatocellular injury from cholestasis?
Predominant AST and ALT elevations suggest hepatocellular injury; predominant alkaline phosphatase elevation suggests cholestasis. Compare each enzyme with its own upper reference limit rather than comparing raw activities. ALT is more liver-specific than AST, which also occurs in skeletal muscle and other tissues. Alkaline phosphatase also originates in bone; a concurrent GGT increase supports a hepatobiliary source. These enzymes indicate injury patterns rather than directly measuring hepatic synthetic capacity. See the [AASLD enzyme interpretation guide](https://www.aasld.org/liver-fellow-network/core-series/back-basics/how-approach-elevated-liver-enzymes).
Apply it
ALT is 12 times its upper reference limit and alkaline phosphatase is 1.5 times its upper limit: the disproportion favors hepatocellular injury. Alkaline phosphatase six times its limit with ALT 1.5 times its limit instead favors cholestasis; increased GGT supports hepatobiliary origin.
Common pitfall: Isolated alkaline phosphatase elevation does not establish liver disease, and isolated AST elevation does not establish hepatic injury. Enzyme magnitude alone does not measure remaining liver function.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
20.How can collection technique produce pseudohyperkalemia?
Potassium is concentrated within cells, so in-vitro cell injury can increase the concentration measured in serum or plasma. Difficult collection, specimen handling, and transport can contribute. Repeated fist pumping can also increase local potassium independently of visible hemolysis. A discordant result should trigger review of collection conditions and specimen integrity. Recollection under controlled conditions helps distinguish an artifact from a real abnormality; an alarming value must not simply be dismissed without investigation.
Apply it
An unexpectedly high potassium follows prolonged fist pumping during a difficult draw. Review the hemolysis assessment and collection history, communicate the discrepancy, and obtain a properly collected repeat specimen through the laboratory's established result-verification process.
Common pitfall: A normal hemolysis index does not exclude every collection-related potassium artifact. Conversely, identifying a possible artifact does not establish that the patient's potassium is normal.
Mayo Clinic Laboratories: Top Gun Phlebotomy—Pseudohyperkalemia
21.How do non-HDL cholesterol and calculated LDL differ?
Non-HDL cholesterol equals total cholesterol minus HDL cholesterol. Friedewald LDL equals total cholesterol minus HDL cholesterol minus estimated VLDL cholesterol. With all concentrations in mg/dL, estimate VLDL cholesterol as triglycerides/5; with all concentrations in mmol/L, use triglycerides/approximately 2.2. Use the conventional Friedewald equation only when triglycerides are below 400 mg/dL, approximately 4.5 mmol/L. Being below this limit does not guarantee accuracy: underestimation remains a concern at low LDL concentrations, especially below 70 mg/dL, and with higher triglycerides.
Apply it
For total cholesterol 224 mg/dL, HDL 44 mg/dL, and triglycerides 150 mg/dL, calculate non-HDL as 180 mg/dL and Friedewald LDL as 224 − 44 − 150/5 = 150 mg/dL. The difference is the estimated VLDL cholesterol term.
Common pitfall: Subtracting triglycerides directly mixes unlike measurements. Do not use the mg/dL divisor of 5 with mmol/L results, or apply the conventional equation at triglycerides of 400 mg/dL or higher.
Dai et al.: Trends in Non–High-Density Lipoprotein Cholesterol Among Children and Adolescents in the United States · TRIGLY_J
22.How is indirect bilirubin calculated and interpreted?
Calculated indirect bilirubin equals total bilirubin minus directly reacting bilirubin, using matching units. It is an operational estimate rather than a separately measured pure chemical fraction. Increased red cell destruction can increase unconjugated bilirubin production, but interpretation requires other hemolysis indicators and relevant liver findings. The calculation identifies a pattern; it does not independently determine whether increased production, impaired conjugation, or another process explains the patient's bilirubin result.
Apply it
Total bilirubin is 3.6 mg/dL and direct bilirubin is 0.7 mg/dL. Calculate indirect bilirubin as 2.9 mg/dL. Increased LDH, reduced haptoglobin, and reticulocytosis would strengthen an accompanying interpretation of increased red cell destruction.
Common pitfall: An increased calculated indirect fraction does not prove hemolysis by itself. Direct-reacting bilirubin is also an assay-defined measurement rather than a perfectly isolated molecular species.
ARUP Laboratories: Hemolytic Anemias · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
23.How is creatinine clearance calculated from a timed collection?
Creatinine clearance equals urine creatinine concentration multiplied by urine flow, divided by plasma creatinine concentration. Urine flow must be expressed as volume per minute, and urine and plasma concentrations must use compatible units. The result is a volume of plasma cleared per unit time. Collection completeness and timing are essential because the calculation treats the collected urine volume as representative of the entire interval; a mathematically correct answer cannot repair an incomplete collection.
Apply it
Urine creatinine is 90 mg/dL, plasma creatinine is 1.0 mg/dL, and a complete 24-hour collection contains 1,440 mL. Urine flow is 1 mL/min, giving an unadjusted creatinine clearance of 90 mL/min.
Common pitfall: Using total daily urine volume as though it were mL/min inflates clearance dramatically. Body-surface-area adjustment is a separate step when specifically requested.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
24.How do pH, carbon dioxide, and bicarbonate identify an acid-base disturbance?
The bicarbonate-to-dissolved-carbon-dioxide relationship determines pH. Reduced bicarbonate tends to lower pH, whereas reduced carbon dioxide tends to raise it. First identify acidemia or alkalemia, then determine which variable changes in the direction explaining that pH. The other variable may represent compensation or an additional primary disturbance. A near-normal pH does not guarantee normal physiology because opposing abnormalities can partly cancel each other while both measured components remain substantially abnormal.
Apply it
An arterial specimen has pH 7.28, bicarbonate 14 mmol/L, and reduced carbon dioxide. The low bicarbonate explains the acidemia, supporting metabolic acidosis; the reduced carbon dioxide acts in the compensating direction rather than causing the acidemia.
Common pitfall: Naming a disorder from bicarbonate alone can miss mixed disturbances. Compensation must be assessed against the primary process, rather than assuming every opposing change is appropriate.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
25.What separates an anion gap from an osmolal gap?
The common potassium-excluding anion gap is sodium minus chloride minus bicarbonate and describes unmeasured ionic charge balance. An osmolal gap compares measured osmolality with a calculated estimate; a common conventional-unit estimate is 2 × sodium + glucose/18 + BUN/2.8. These gaps answer different questions about unmeasured anions and unaccounted osmoles. Specify the equation, units, and comparison interval because laboratories may use different calculation conventions and analytical methods.
Apply it
Sodium is 140, chloride 104, and bicarbonate 16 mmol/L, giving an anion gap of 20 mmol/L. Glucose 90 mg/dL and BUN 14 mg/dL give calculated osmolality near 290 mOsm/kg; compare that estimate separately with measured osmolality.
Common pitfall: An increased anion gap does not automatically imply an increased osmolal gap. Neither gap identifies a specific toxic substance without additional evidence and appropriate testing.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
26.How do TIBC, UIBC, and transferrin saturation relate?
Total iron-binding capacity represents available transferrin iron-binding capacity, while unsaturated iron-binding capacity represents the portion not occupied by iron. With compatible units, TIBC equals serum iron plus UIBC, and percent transferrin saturation equals serum iron divided by TIBC multiplied by 100. These relationships help check internal consistency and quantify occupancy. Interpretation still requires ferritin and clinical context because an isolated iron concentration does not establish total body iron stores.
Apply it
Serum iron is 45 micrograms/dL and UIBC is 255 micrograms/dL. Calculate TIBC as 300 micrograms/dL and transferrin saturation as 15%. Review ferritin and inflammation context before assigning an explanation for the low saturation.
Common pitfall: Using UIBC as the denominator overestimates saturation. Mixing concentration units between serum iron and binding capacity can also create a convincing but incorrect percentage.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline · ARUP Laboratories: Thalassemias
27.How does the albumin-to-globulin ratio expose a protein pattern?
Calculated globulin equals total protein minus albumin; the albumin-to-globulin ratio equals albumin divided by that calculated globulin. The ratio can change because albumin decreases, globulins increase, or both occur. It summarizes a relationship rather than identifying the protein responsible. Additional separation methods, such as electrophoresis, can characterize protein distributions when indicated. Check that total protein and albumin come from compatible specimens and use the same units before calculating.
Apply it
Total protein is 8.8 g/dL and albumin is 3.2 g/dL. Calculated globulin is 5.6 g/dL and the A/G ratio is approximately 0.57. Describe the relative globulin predominance without declaring a specific monoclonal protein.
Common pitfall: A low A/G ratio is not synonymous with a monoclonal gammopathy. A ratio cannot distinguish a narrow monoclonal component from a broad polyclonal increase.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
28.Why does specimen timing matter in therapeutic drug monitoring?
Drug concentrations change during absorption, distribution, metabolism, and elimination. A concentration can be compared meaningfully with a target only when the sampling time matches the intended interpretation, such as a specified predose trough. Dose history, collection time, and changing clearance are therefore part of the result. A therapeutic monitoring concentration and a toxicology screening result also answer different questions: quantitative exposure at a defined time versus detection within a method's analytical scope.
Apply it
A specimen requested as a trough was actually collected shortly after administration. Identify the timing mismatch before comparing it with a trough target, and document dose and collection times so the result is not interpreted using an inappropriate reference.
Common pitfall: A number outside a therapeutic interval does not establish toxicity without timing and clinical context. A negative screening assay also does not exclude substances it cannot detect.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
Hematology20–25%
29.How do RBC indices distinguish cell size from hemoglobin concentration?
MCV describes average red cell volume, MCH describes average hemoglobin mass per cell, and MCHC describes hemoglobin concentration within the red cell volume. Using conventional units, MCV equals hematocrit × 10/RBC count, MCH equals hemoglobin × 10/RBC count, and MCHC equals hemoglobin × 100/hematocrit. These indices characterize an anemia pattern rather than establish its cause. Internally inconsistent indices should prompt review for analytical or specimen-related problems.
Apply it
Hemoglobin is 9 g/dL, hematocrit 30%, and RBC count 5.0 million/microliter. Calculate MCV 60 fL, MCH 18 pg, and MCHC 30 g/dL, describing small cells with reduced hemoglobin concentration before investigating the cause.
Common pitfall: Using hematocrit as 0.30 in a formula designed for 30% creates a hundredfold error. Verify the unit convention before substituting numerical values.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
30.When does a nucleated red cell count require WBC correction?
Some counting methods include nucleated red cells in the apparent leukocyte count. When correction is required, corrected WBC equals the uncorrected count multiplied by 100 and divided by 100 plus nucleated red cells per 100 WBCs. The issuer specifically includes correction when more than 10 nucleated red cells are present. Determine whether the instrument already excludes or corrects these cells, because applying the formula twice would falsely reduce the reportable WBC count.
Apply it
An uncorrected count is 18,000/microliter and the differential finds 20 nucleated red cells per 100 WBCs. Calculate 18,000 × 100/120 = 15,000 WBCs/microliter, after confirming that the original count includes nucleated red cells.
Common pitfall: Correcting an already corrected automated result underestimates leukocytes. The denominator uses nucleated red cells per 100 WBCs, not a percentage of all nucleated cells.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
31.Why is an absolute reticulocyte count more informative than a percentage alone?
Reticulocytes reflect recent marrow red cell output. A percentage depends on the number of circulating red cells, so anemia can make a percentage appear reassuring despite limited absolute production. Absolute reticulocytes equal RBC count multiplied by the reticulocyte fraction. Hemolysis generally increases marrow output, but simultaneous iron deficiency or marrow suppression can blunt that response. Interpret reticulocytes alongside hemoglobin, the severity and duration of anemia, and biochemical evidence of cell destruction.
Apply it
An RBC count of 2.5 million/microliter with 2% reticulocytes yields 50,000 reticulocytes/microliter. Although 2% may look unremarkable, assess whether that output is sufficient for the patient's anemia rather than judging the percentage alone.
Common pitfall: A normal-range reticulocyte percentage is not automatically an adequate marrow response. It can conceal reduced absolute production when the circulating RBC population is small.
ARUP Laboratories: Hemolytic Anemias · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
32.Which findings distinguish iron deficiency from thalassemia trait?
Both iron deficiency and thalassemia can produce microcytosis. Iron deficiency commonly reduces ferritin when inflammation is absent; thalassemia trait often produces striking microcytosis with a relatively preserved or increased RBC count. Iron studies assess iron availability and stores, while hemoglobin analysis evaluates globin abnormalities. Increased HbA2 commonly supports beta-thalassemia trait. Normal adult hemoglobin fractions do not exclude alpha-thalassemia trait, which may require deletion-focused molecular testing. Iron deficiency and thalassemia can coexist and complicate interpretation.
Apply it
A patient has very low MCV, mild anemia, a relatively high RBC count, and ferritin that is not reduced without evidence of inflammation. Prioritize a thalassemia investigation. If adult hemoglobin fractions are unremarkable, retain alpha-thalassemia as a possibility rather than ending the evaluation.
Common pitfall: Normal ferritin during inflammation does not reliably exclude iron deficiency. A screening index cannot establish a genotype, and normal HbA2 does not exclude all thalassemias. Recent transfusion can obscure native hemoglobin fractions.
33.How does BCR::ABL1 testing distinguish chronic myeloid leukemia from other causes of leukocytosis?
Chronic myeloid leukemia is a myeloid neoplasm defined by BCR::ABL1 in the appropriate clinical and laboratory setting. The fusion usually arises from t(9;22), the Philadelphia chromosome rearrangement. Cytogenetics evaluates chromosomes, FISH detects the rearrangement, and RT-PCR detects fusion transcripts. Persistent leukocytosis alone does not establish CML. Morphology and genetic testing supply complementary evidence. The [European LeukemiaNet laboratory recommendations](https://pmc.ncbi.nlm.nih.gov/articles/PMC10624636/) explain these diagnostic roles.
Apply it
A patient with persistent leukocytosis is investigated for CML. Demonstration of BCR::ABL1 supports the diagnosis in the appropriate morphologic setting; chromosome analysis can additionally identify other clonal abnormalities. A normal-looking conventional karyotype cannot exclude a cryptic fusion detectable by another method.
Common pitfall: A limited RT-PCR assay can miss atypical transcripts. BCR::ABL1 also occurs in other leukemia settings, so interpret the fusion with morphology and disease context rather than assigning CML from the molecular result alone.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
34.What makes macrocytosis megaloblastic rather than simply large-cell anemia?
Megaloblastosis results from impaired DNA synthesis and defective nuclear maturation. Macro-ovalocytes and hypersegmented neutrophils support this mechanism, while vitamin B12 deficiency, folate deficiency, and certain drugs are important causes. Macrocytosis alone is broader and can occur through other mechanisms, including reticulocytosis. Morphology therefore directs testing but is not independently diagnostic. A low reticulocyte response supports ineffective production, whereas increased reticulocytes should prompt consideration of hemolysis or recovery.
Apply it
A patient has anemia, increased MCV, macro-ovalocytes, and hypersegmented neutrophils with low reticulocyte output. Investigate impaired DNA synthesis and vitamin status rather than attributing the large cells to a strong regenerative marrow response.
Common pitfall: An increased MCV does not by itself establish B12 deficiency. Morphology, reticulocyte response, nutritional testing, and medication history help separate competing causes.
35.Which combined laboratory findings support hemolysis?
Accelerated red cell destruction commonly produces increased LDH and unconjugated bilirubin, reduced haptoglobin, and increased reticulocytes when the marrow can respond. Each finding has alternative explanations, so the combined pattern is more informative than any isolated result. After establishing hemolysis, morphology and targeted tests help identify the mechanism. A direct antiglobulin test evaluates immune coating, while schistocytes, spherocytes, or other findings guide different secondary investigations without independently establishing one diagnosis.
Apply it
A falling hemoglobin accompanies increased LDH and indirect bilirubin, low haptoglobin, and reticulocytosis. Recognize a coherent hemolytic pattern, then use the smear and direct antiglobulin testing to help distinguish fragmentation, immune destruction, and other mechanisms.
Common pitfall: Spherocytes alone do not distinguish hereditary membrane disease from immune hemolysis. A weak marrow response also does not exclude hemolysis when production is impaired.
36.Why can an enzyme assay miss a red cell enzymopathy?
Measured red cell enzyme activity reflects the cells present in the tested specimen, not simply the patient's inherited genotype. Cell age, reticulocyte enrichment, recent transfusion, and leukocyte contamination can influence results. In a suspected enzymopathy such as G6PD deficiency, hemolysis and morphology provide context, but enzyme testing requires careful interpretation. A seemingly normal activity result can therefore be discordant with a convincing clinical and laboratory pattern and may require appropriately timed reassessment or complementary testing.
Apply it
A patient is tested for an RBC enzyme defect soon after hemolysis and transfusion. Before accepting normal activity as exclusion, identify the mixed cell population and altered cell ages as factors that can complicate the assay's interpretation.
Common pitfall: A normal activity result from a biologically unrepresentative specimen is not equivalent to a normal genotype. Conversely, Heinz bodies are suggestive rather than uniquely diagnostic.
37.How do absolute leukocyte counts prevent percentage-based misinterpretation?
A differential percentage describes the proportion of leukocytes in a category, while an absolute count describes how many are present per volume. Calculate an absolute count by multiplying total WBC by the category's decimal fraction. A high percentage can coexist with a low absolute count when total leukocytes are reduced. Morphology supplies additional information about maturation and abnormal populations, but percentage, absolute number, and cellular appearance should not be substituted for one another.
Apply it
Total WBC is 2.0 × 10^9/L and neutrophils are 60%. The absolute neutrophil count is 1.2 × 10^9/L. A seemingly ordinary percentage therefore does not establish an ordinary absolute neutrophil concentration in this specimen.
Common pitfall: Calling a population increased solely because its percentage is high can confuse relative predominance with absolute expansion. Always inspect the total WBC denominator.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
38.How can platelet clumping mimic thrombocytopenia?
Automated platelet enumeration depends on recognizing individual platelets within the method's counting criteria. Aggregates may be excluded or classified incorrectly, creating a falsely low count. A low result with instrument flags or clinical discordance should therefore prompt smear assessment for clumps and other interferences. A suitably collected alternative specimen can help establish the actual count, with any dilution correction applied when required. Confirming the artifact prevents confusing an in-vitro counting problem with platelet destruction.
Apply it
An unexpectedly low platelet count is accompanied by an aggregation flag, and the smear shows clumps near the feathered edge. Investigate pseudothrombocytopenia and obtain a suitable repeat specimen rather than interpreting the initial count as confirmed severe thrombocytopenia.
Common pitfall: Repeating the same clumped tube can reproduce the artifact. The repeat specimen's anticoagulant and dilution must be considered before comparing its numerical result.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline · EDTA-induced pseudothrombocytopenia with Citrate correction
39.How do PT, aPTT, and mixing studies narrow a coagulation problem?
PT and aPTT interrogate overlapping but different coagulation pathways. Isolated PT prolongation suggests possibilities such as factor VII deficiency, while isolated aPTT prolongation has intrinsic-pathway, anticoagulant, and inhibitor explanations. Mixing patient plasma with normal plasma supplies missing factors; correction favors deficiency, while persistent prolongation suggests an inhibitor or drug effect. Some inhibitors are time-dependent, so immediate and incubated results may differ. Clinical bleeding, thrombosis, medications, and specimen quality determine the next discriminating tests.
Apply it
A patient with new bleeding has isolated prolonged aPTT. A mix corrects immediately but becomes prolonged after incubation. Recognize a time-dependent inhibitor pattern and pursue appropriate factor activity and inhibitor testing rather than labeling a simple deficiency.
Common pitfall: Immediate correction does not exclude a time-dependent inhibitor. A prolonged aPTT also does not universally imply bleeding, because some causes are asymptomatic or thrombosis-associated.
ARUP Laboratories: Prolonged Clotting Time Evaluation · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
40.Why does normal fibrinogen fail to exclude early DIC?
Disseminated intravascular coagulation involves widespread coagulation activation, fibrin formation, consumption of platelets and factors, and secondary fibrin breakdown. Fibrinogen may decrease, but it is also an acute-phase reactant and can remain within range despite ongoing consumption. Falling platelets, increasing D-dimer, prolonged PT, compatible illness, and serial changes provide a more complete picture. Diagnosis requires combined clinical and laboratory assessment rather than a single mandatory abnormality or an isolated elevated D-dimer.
Apply it
A septic patient develops falling platelets, prolonged PT, and increasing D-dimer while fibrinogen remains within range. Keep DIC in the differential and assess serial results; preserved fibrinogen does not cancel the other evidence of evolving consumption.
Common pitfall: Excluding DIC because fibrinogen is normal ignores concurrent acute-phase production. An elevated D-dimer alone is also insufficient because fibrin turnover increases in many conditions.
Immunology5–10%
41.How do primary and secondary antibody responses differ?
A primary response develops after initial antigen recognition and commonly begins with IgM before class switching and affinity maturation. Memory cells enable a faster, stronger response after subsequent exposure, often with prominent class-switched antibody such as IgG. Immunoglobulin class therefore supplies useful biologic context but does not function as a universal clock for infection. Antibody persistence, repeat exposure, and assay specificity can complicate attempts to infer timing from one positive serologic result.
Apply it
A patient has a documented prior antibody response and later re-exposure to the same antigen. Explain why a rapid IgG response can reflect immune memory, and avoid requiring a new prominent IgM response before recognizing secondary immunity.
Common pitfall: IgM positivity does not universally prove a new infection, and IgG positivity does not universally prove protection. Interpret classes within the validated disease-specific testing framework.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline · CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
42.What distinguishes classical from alternative complement activation?
The classical complement pathway can be initiated by antigen-bound antibody, whereas the alternative pathway can amplify complement activation without requiring antigen-specific antibody. Both converge on C3 activation and downstream effector mechanisms, including opsonization and membrane attack. This shared endpoint explains why complement activity can be relevant to both innate defense and antibody-associated processes. Interpreting a complement-related result requires distinguishing pathway initiation, individual component abundance, and functional activity rather than treating them as identical measurements.
Apply it
An exercise asks whether complement activation always requires a prior adaptive antibody response. Use the alternative pathway to explain why it does not, while identifying antibody-associated classical activation as a separate route to common downstream complement effects.
Common pitfall: Complement is not a single antibody or a single protein. A concentration measurement for one component cannot by itself establish that every pathway functions normally.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
43.How do syphilis assays, dilution studies, and titers answer different questions?
Treponemal assays detect antibodies to T. pallidum antigens; nontreponemal assays detect antibodies reacting with lipoidal antigens. A reactive treponemal screen with nonreactive RPR requires adjudication by a different treponemal assay, such as TPPA. Treponemal reactivity can persist after treatment. When clinical findings conflict with nonreactive RPR, serial dilutions can investigate prozone: excess antibody prevents visible lattice formation. For follow-up, a fourfold nontreponemal titer change is two twofold dilution steps, using the same method.
Apply it
A reactive treponemal immunoassay with nonreactive RPR calls for a second treponemal assay and treatment-history review. Separately, RPR decreasing from 1:64 to 1:16 by the same method is a fourfold decrease. Suspected prozone requires a dilution series rather than another undiluted RPR alone.
Common pitfall: RPR and VDRL titers are not interchangeable. A change from 1:8 to 1:16 is only twofold. Treponemal assay signals do not quantify treatment response, and routine dilution of every negative RPR is unnecessary.
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
44.How do autoantibody tests investigate pernicious anemia?
Pernicious anemia impairs vitamin B12 absorption through loss of adequate intrinsic-factor function. In confirmed B12 deficiency, intrinsic-factor blocking antibodies provide specific evidence for this autoimmune cause. Parietal-cell antibodies are more sensitive but less specific and can occur in other gastric disorders. A negative intrinsic-factor antibody test therefore does not exclude pernicious anemia. Distinguish establishing the vitamin deficiency from identifying the immune mechanism responsible for it.
Apply it
A patient has confirmed B12 deficiency and megaloblastic findings. Positive intrinsic-factor blocking antibodies support pernicious anemia as the cause. If this antibody test is negative, consider parietal-cell antibodies and other supporting gastric investigations rather than assuming dietary deficiency.
Common pitfall: A B12 concentration does not identify the cause of deficiency. Conversely, isolated parietal-cell antibodies are less specific than intrinsic-factor antibodies and require the appropriate clinical and biochemical context.
45.How does phospholipid dependence distinguish lupus anticoagulant from a factor-specific inhibitor?
Lupus anticoagulants interfere with phospholipid-dependent clotting reactions in vitro. Testing compares phospholipid-sensitive screening conditions with confirmatory conditions containing more phospholipid; shortening with added phospholipid supports phospholipid dependence. Mixing studies, confirmatory assays, and exclusion of anticoagulant interference are interpreted together. Factor-specific inhibitors can also prolong clotting times and interfere with lupus-anticoagulant assays. The laboratory name does not imply a bleeding disorder or independently establish systemic lupus erythematosus.
Apply it
An unexplained prolonged aPTT with an inhibitor pattern is evaluated using validated lupus-anticoagulant testing after drug interference is assessed. Phospholipid-dependent correction supports lupus anticoagulant. New severe bleeding with low factor VIII instead requires investigation for a factor VIII inhibitor and possible assay interference.
Common pitfall: A prolonged aPTT alone cannot identify lupus anticoagulant. Lupus anticoagulant generally does not cause bleeding, and factor VIII inhibitors can produce false-positive results in some lupus-anticoagulant assays.
lecture-slides.pdf · ARUP Laboratories: Prolonged Clotting Time Evaluation
Microbiology15–20%
46.How does specimen quality shape Gram-stain interpretation?
A Gram stain provides bacterial staining reaction, morphology, arrangement, and information about host cells and specimen composition. These observations must be linked to the collection site and specimen quality. Organisms in a contaminated sample may reflect surface flora rather than the intended infected site, while failure to see organisms does not establish sterility. The decision is to judge whether the material represents the clinical question before treating every observed organism as the causative pathogen.
Apply it
A specimen submitted as lower respiratory material contains abundant squamous epithelial cells and mixed bacterial morphologies. Recognize possible oral contamination and assess it against the laboratory's sputum-quality criteria before giving the findings the significance of a representative lower respiratory sample.
Common pitfall: A recognizable bacterial shape does not compensate for an unrepresentative specimen. Gram morphology supplies an early classification, not definitive species identification or susceptibility.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline · WHO, CDC, and CLSI: Laboratory Quality Management System Handbook
47.How does tube coagulase refine presumptive staphylococcal identification?
Identification of staphylococci combines colony and microscopic findings with validated biochemical or other identification methods. Tube coagulase is an important discriminator supporting presumptive Staphylococcus aureus identification. Slide agglutination or clumping reactions are not identical to tube coagulase; some other staphylococci can produce misleading presumptive reactions. The CDC identification chart therefore uses a branching sequence rather than one visual impression. Follow the complete validated pathway when preliminary and confirmatory findings disagree.
Apply it
An isolate produces a positive slide clumping reaction but a negative tube coagulase result. Continue the identification pathway rather than reporting S. aureus solely from clumping; other clinically significant staphylococci can require further differentiation.
Common pitfall: A positive rapid clumping reaction is not an unconditional species identification. Conversely, coagulase-negative status does not mean the organism is incapable of causing serious disease.
48.How can a worked biochemical pattern support presumptive E. coli identification?
For a non-stool isolate, begin with the combined pattern rather than one reaction: a Gram-negative rod that is oxidase-negative and spot-indole-positive enters the CDC E. coli identification pathway. Lactose fermentation on MacConkey or EMB agar and beta-hemolysis provide additional discrimination. The lactose-positive, beta-hemolytic branch supports presumptive E. coli identification within that pathway. Other branches require additional tests. See the [CDC E. coli non-stool identification chart](https://reach.cdc.gov/sites/default/files/job-aids-resources/Escherichia_coli_non-stool_ID_Chart_Branded_508.pdf).
Apply it
A urine isolate is a Gram-negative rod, oxidase-negative, spot-indole-positive, lactose-fermenting on MacConkey agar, and beta-hemolytic on blood agar. The combined findings support presumptive E. coli through the CDC pathway; complete any additional identification required by the validated laboratory method.
Common pitfall: Lactose fermentation alone does not establish E. coli, and absence of beta-hemolysis does not exclude it. Apply the appropriate branch rather than treating one biochemical reaction as species-specific.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
49.Why do resistance genes and phenotypic susceptibility answer different questions?
Molecular resistance tests detect specified genetic determinants, while phenotypic tests measure growth response under defined antimicrobial conditions. A negative targeted molecular result excludes only the targets assessed, not every resistance mechanism. Phenotypic interpretation also depends on organism identity, method, and applicable interpretive criteria. Discordant findings require investigation rather than selective acceptance of whichever result appears more reassuring. For tuberculosis, CDC explicitly describes complementary roles for molecular and growth-based drug susceptibility testing.
Apply it
A targeted assay detects no listed resistance determinant, but validated phenotypic testing indicates resistance. Review identification, assay coverage, quality controls, and possible alternative mechanisms before finalizing an interpretation that treats the molecular result as universal susceptibility.
Common pitfall: Absence of one resistance gene is not proof of antimicrobial susceptibility. Conversely, a detected determinant must be interpreted within the assay's validated organism and reporting context.
CDC: Clinical and Laboratory Diagnosis for Tuberculosis · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
50.What can an acid-fast smear establish about tuberculosis?
An acid-fast smear detects organisms with the relevant staining characteristics and can provide an estimate of bacillary burden. It does not identify every acid-fast organism as Mycobacterium tuberculosis complex. A negative smear also does not exclude tuberculosis because organism numbers may be below microscopic detection. Interpret smear findings with nucleic acid testing, culture, and clinical information. The decisive distinction is rapid staining evidence versus species-level confirmation and the broader assessment of disease.
Apply it
A respiratory specimen is acid-fast smear positive. Report the verified smear finding promptly, while retaining material for recommended identification and culture testing. Do not convert the stain result alone into a definitive M. tuberculosis complex identification.
Common pitfall: Acid-fast positivity is not species specificity. Negative microscopy likewise cannot establish absence of tuberculosis in a patient whose clinical presentation remains concerning.
51.How does an MIC become a susceptibility interpretation?
The minimum inhibitory concentration is the lowest tested antimicrobial concentration that inhibits bacterial growth under the method's defined conditions. Interpret it using the applicable organism–drug breakpoint, rather than treating a small number as universally susceptible. Susceptible MICs fall at or below the susceptible breakpoint; resistant MICs fall at or above the resistant breakpoint. Disk-diffusion zone interpretation runs in the opposite direction. See [CDC MIC teaching](https://www.cdc.gov/narms/about/antibiotics-tested.html) and [FDA interpretive-category definitions](https://www.fda.gov/drugs/development-resources/fda-recognized-antimicrobial-susceptibility-test-interpretive-criteria).
Apply it
In a broth dilution example, growth occurs at 0.5 and 1 microgram/mL but not at 2, 4, or 8 micrograms/mL. The MIC is 2 micrograms/mL. Assign a category only after checking the applicable breakpoint for that identified organism, antimicrobial, and testing context.
Common pitfall: Do not rank different drugs by raw MIC alone: their breakpoints and achievable exposures differ. A susceptibility category also depends on the dosing and infection-site assumptions underlying its criteria.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
52.How does direct viral detection differ from antibody testing?
Direct methods detect a viral component, such as nucleic acid or antigen, in the sampled material. Serologic methods detect the host's antibody response, which develops and persists on a different time course. The best specimen and collection timing therefore depend on which question the assay is designed to answer. A negative direct test can reflect sampling or timing, while a positive antibody test may reflect past exposure rather than current virus at the tested site.
Apply it
A patient is evaluated early in an acute respiratory illness. Recognize that a validated respiratory nucleic acid test addresses viral material at the sampled site, whereas an isolated antibody result answers a different question about the host response.
Common pitfall: Antibody detection and viral detection are not interchangeable evidence of current infection. A negative test is meaningful only within its specimen, timing, and analytical limitations.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
53.How should persistent malaria suspicion guide repeat testing?
Thick and thin blood films provide complementary information: thick films improve parasite detection, while thin films support species identification and parasitemia assessment. Nonimmune patients may be symptomatic at parasite densities initially below detection. When suspicion remains high after a negative smear, CDC recommends repeating microscopy every 12–24 hours for three sets. Rapid diagnostic tests do not eliminate the need for microscopy, which supplies information necessary to characterize the infection and assess parasite burden.
Apply it
A febrile traveler has one negative smear but a convincing exposure history. Arrange repeat thick and thin films at the recommended intervals rather than closing the investigation, and ensure a rapid-test result does not replace the microscopy needed for characterization.
Common pitfall: One negative film does not exclude malaria under persistent high suspicion. A rapid test also cannot supply all species and parasite-density information provided by microscopy.
54.Why is fungal morphology insufficient for every yeast identification?
Microscopy can reveal fungal elements and help distinguish broad forms such as yeasts and hyphae, but morphology does not reliably resolve every species. Candida auris is especially important because routine phenotypic appearances do not easily distinguish it from other yeasts. Reliable identification requires an appropriate validated method, such as MALDI-TOF MS with a suitable reference database. A preliminary yeast finding and a confirmed species identification therefore represent different levels of evidence.
Apply it
An isolate appears as a yeast, but its identification is unusual and C. auris is a concern. Confirm it using a validated identification method with appropriate database coverage instead of assigning a species from colony appearance alone.
Common pitfall: A technology name alone does not guarantee correct identification. Database coverage, validated workflow, and recognition of unusual results remain essential even with automated systems.
CDC: Laboratory Information for C. auris · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
55.How does C. auris colonization screening differ from diagnosing invasive infection?
Colonization screening asks whether a patient carries C. auris, commonly using skin swabs; CDC identifies real-time PCR as the preferred detection method for this purpose. Invasive infection requires interpretation of clinical specimens and the patient's condition. A positive screening swab does not by itself establish bloodstream infection, but it remains important for preventing transmission. Possible or confirmed C. auris findings require prompt communication to infection prevention and appropriate public health reporting processes.
Apply it
A screening skin swab is positive for C. auris in a patient without evidence of invasive disease. Interpret the result as carriage evidence and promptly notify infection prevention, while keeping the separate question of clinical infection tied to relevant clinical findings.
Common pitfall: Absence of invasive disease does not make colonization unimportant. Conversely, a positive surveillance swab should not be relabeled as a positive blood culture.
Laboratory Operations5–10%
56.What separates precision from accuracy in laboratory measurement?
Precision describes how closely repeated measurements agree, whereas accuracy concerns agreement with an accepted value. A method can produce tightly clustered results that are consistently displaced by bias. The coefficient of variation, calculated as standard deviation divided by mean multiplied by 100, expresses relative imprecision. It does not measure bias. Evaluating a method therefore requires both repeatability information and comparison with suitable assigned or reference values across the concentrations relevant to its use.
Apply it
A control repeatedly gives 110 mg/dL with a standard deviation of 1 mg/dL, but its assigned value is 100 mg/dL. Recognize strong repeatability with positive bias; the small CV does not establish acceptable accuracy.
Common pitfall: A low CV cannot prove that results are centered correctly. Comparing CVs across concentration levels also requires attention to the assay's performance characteristics.
WHO, CDC, and CLSI: Laboratory Quality Management System Handbook
57.How do control shifts and trends reveal systematic change?
A shift is a sustained change to a different level, while a trend is progressive movement in one direction. Both may signal systematic problems such as calibration changes, reagent deterioration, or instrument drift. Their interpretation depends on the laboratory's established control rules and the full chart. When a run fails acceptance criteria, withhold affected patient results, investigate, correct the cause, and demonstrate acceptable performance before release; repetition alone does not establish that the problem disappeared.
Apply it
After a reagent change, successive control values remain consistently above the previous mean and violate established acceptance rules. Investigate the reagent and calibration change, hold affected results, and verify correction with acceptable controls before resuming release.
Common pitfall: Repeating controls until one value passes can conceal an unresolved systematic problem. Altering control limits merely to accept the new results removes their protective function.
WHO, CDC, and CLSI: Laboratory Quality Management System Handbook
58.How do dilution factors and Beer's law support quantitative testing?
A dilution factor equals final volume divided by sample volume. Under appropriate linear conditions, absorbance follows Beer's law and is proportional to concentration at a fixed path length. A diluted specimen's measured concentration must therefore be multiplied by the dilution factor to recover the original concentration. The calculation is valid only when the dilution is permitted by the method and the diluted measurement lies within the analytical range with acceptable matrix and reaction conditions.
Apply it
Mix 0.2 mL of sample with 0.8 mL of approved diluent. The dilution factor is 5. A measured result of 36 mg/dL corresponds to 180 mg/dL in the original sample, provided the method accepts that dilution.
Common pitfall: One part sample plus four parts diluent is a fivefold dilution. Extrapolating absorbance beyond the validated linear range does not become reliable through arithmetic.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
59.Why does disease prevalence change positive predictive value?
Sensitivity is the proportion of affected people testing positive, and specificity is the proportion of unaffected people testing negative. Positive predictive value instead asks what proportion of positive results represent affected people. With unchanged sensitivity and specificity, lower prevalence usually lowers positive predictive value because unaffected people contribute more false positives relative to true positives. This distinction explains why a useful screening method can still require confirmation, particularly in a population with low disease prevalence.
Apply it
Among 1,000 people, 10 have disease. A test detects 9 of them and falsely identifies 10 unaffected people as positive. Its positive predictive value is 9/19, about 47%, despite detecting most affected individuals.
Common pitfall: Sensitivity is not the probability of disease after a positive result. That posttest interpretation also depends on specificity and how common the disease is.
Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
60.How should safety controls and immediate first aid match the laboratory hazard?
Appropriate biological containment controls infectious aerosols; a chemical fume hood controls hazardous chemical vapors. Select equipment using the actual hazard, cabinet design, exhaust configuration, and current certification rather than assuming interchangeability. See [CDC laboratory safety guidance](https://www.cdc.gov/mmwr/preview/mmwrhtml/su6101a1.htm). After blood or potentially infectious material contacts a mucous membrane, immediately flush the exposed membrane with water, promptly report the exposure, and obtain exposure evaluation. Flushing is specified in [OSHA 1910.1030(d)(2)(vi)](https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030).
Apply it
Blood splashes into a worker's eye: begin flushing with water immediately, then promptly report and obtain occupational exposure evaluation without waiting for symptoms. For subsequent infectious aerosol work, use suitable certified biological containment; for volatile chemical work, select ventilation designed to control those vapors.
Common pitfall: Gloves do not control eye splashes or inhalation exposure. HEPA filtration does not by itself remove chemical vapors, and reporting an exposure must not delay immediate flushing.
WHO, CDC, and CLSI: Laboratory Quality Management System Handbook · Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give Chemistry and Hematology the largest study blocks; pair every calculation with units, specimen assumptions, and an interpretation.
- Build Blood Banking decisions around concordant ABO results, antibody history, antigen-negative selection, and the distinct purposes of component modifications.
- Practise distinguishing true disease patterns from hemolysis, collection artifacts, platelet clumping, and method-specific reagent strip limitations.
- Link microbiology findings to specimen quality, biochemical identification patterns, susceptibility breakpoints, complementary test methods, and timely communication.
- Connect immune disease testing to its mechanism: intrinsic-factor antibodies, phospholipid-dependent inhibitors, complement activation, and disease-specific serologic algorithms.
- Use the official outline to extend beyond these selected concepts, including donor requirements, component specifications, additional enzyme patterns, acute and lymphoid neoplasms, and the wider organism syllabus.
A practical preparation plan
1. Map the full outline
Mark each official topic as secure, developing, or unfamiliar. Allocate study time using the published domain ranges while preserving regular review of every domain.
2. Create a calculation worksheet
Work the issuer-listed formulas from blank paper. Include concentration units, time conversions, dilution factors, and a reasonableness check for each answer.
3. Compare competing mechanisms
Use paired examples: iron deficiency versus thalassemia, hemolysis versus impaired production, antibody history versus current screen, and phenotypic resistance versus targeted gene detection.
4. Complete the independent questions
Choose one answer before reading the explanation. For every missed item, write the decisive cue and explain why each competing option does not fit.
5. Rehearse active recall
Answer flashcards aloud with a short mechanism, calculation, or boundary. Revisit uncertain cards after intervening study rather than relying on immediate recognition.
6. Practise integrated result review
Combine specimen integrity, control status, analytical limits, and disease correlation in short cases. Finish by checking uncovered official-outline topics and the issuer's examination reference ranges.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ASCP BOC: Medical Laboratory Technician
- Medical Laboratory Technician - MLT(ASCP) and MLT(ASCPi): Examination Content Guideline
- Canadian Blood Services: Pre-transfusion testing
- Canadian Blood Services: Irradiated, washed and CMV seronegative blood components
- Siemens Healthcare Diagnostics: Urinalysis Reagent Strips Package Insert
- Mayo Clinic Laboratories: Top Gun Phlebotomy—Pseudohyperkalemia
- NIDDK: Thyroid Tests
- NIDDK: The A1C Test & Diabetes
- ARUP Laboratories: Megaloblastic Anemia
- ARUP Laboratories: Thalassemias
- ARUP Laboratories: Hemolytic Anemias
- ARUP Laboratories: Prolonged Clotting Time Evaluation
- ARUP Laboratories: Disseminated Intravascular Coagulation
- CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
- CDC: Staphylococci ID Chart
- CDC: Clinical Testing and Diagnosis for Malaria
- CDC: Clinical and Laboratory Diagnosis for Tuberculosis
- CDC: Laboratory Information for C. auris
- WHO, CDC, and CLSI: Laboratory Quality Management System Handbook
- Dai et al.: Trends in Non–High-Density Lipoprotein Cholesterol Among Children and Adolescents in the United States
- TRIGLY_J
- view
- EDTA-induced pseudothrombocytopenia with Citrate correction
- lecture-slides.pdf
- sicu-handbook-6-2025.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.